About: Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $20.91 (+1.26%)
VOR NASDAQ Vor Biopharma Inc
Vor Biopharma Inc share price
Atividade de preço de VOR
Último preço
$ 20,910
Variação (24h)
0,26 USD (1,26%)
Volume
948.29K
Volume (média 4 sem.)
-
Abertura
$ 20,80
Variação do dia
$ 20,66 - $ 21,59
Fechamento anterior
$ 20,65
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
VOR price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals